| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3875799
[patent_doc_number] => 05728542
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Disposable test kit apparatus and method for bacteria'
[patent_app_type] => 1
[patent_app_number] => 8/614813
[patent_app_country] => US
[patent_app_date] => 1996-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 4866
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728542.pdf
[firstpage_image] =>[orig_patent_app_number] => 614813
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/614813 | Disposable test kit apparatus and method for bacteria | Mar 7, 1996 | Issued |
Array
(
[id] => 4135337
[patent_doc_number] => 06015663
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains'
[patent_app_type] => 1
[patent_app_number] => 8/609334
[patent_app_country] => US
[patent_app_date] => 1996-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 9
[patent_no_of_words] => 10611
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015663.pdf
[firstpage_image] =>[orig_patent_app_number] => 609334
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/609334 | Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains | Feb 29, 1996 | Issued |
Array
(
[id] => 4210267
[patent_doc_number] => 06086903
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Personal treatment compositions and/or cosmetic compositions containing enduring perfume'
[patent_app_type] => 1
[patent_app_number] => 8/606881
[patent_app_country] => US
[patent_app_date] => 1996-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33785
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086903.pdf
[firstpage_image] =>[orig_patent_app_number] => 606881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/606881 | Personal treatment compositions and/or cosmetic compositions containing enduring perfume | Feb 25, 1996 | Issued |
Array
(
[id] => 3802312
[patent_doc_number] => 05830636
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'HEV orf-2 monoclonal antibodies and methods for using same'
[patent_app_type] => 1
[patent_app_number] => 8/605658
[patent_app_country] => US
[patent_app_date] => 1996-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7154
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830636.pdf
[firstpage_image] =>[orig_patent_app_number] => 605658
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/605658 | HEV orf-2 monoclonal antibodies and methods for using same | Feb 21, 1996 | Issued |
Array
(
[id] => 4291843
[patent_doc_number] => 06183949
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'HCV peptide antigens and methods for the determination of HCV'
[patent_app_type] => 1
[patent_app_number] => 8/604365
[patent_app_country] => US
[patent_app_date] => 1996-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4727
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/183/06183949.pdf
[firstpage_image] =>[orig_patent_app_number] => 604365
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/604365 | HCV peptide antigens and methods for the determination of HCV | Feb 20, 1996 | Issued |
Array
(
[id] => 3879164
[patent_doc_number] => 05776468
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A'
[patent_app_type] => 1
[patent_app_number] => 8/525638
[patent_app_country] => US
[patent_app_date] => 1996-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12010
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776468.pdf
[firstpage_image] =>[orig_patent_app_number] => 525638
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/525638 | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A | Feb 11, 1996 | Issued |
Array
(
[id] => 1459157
[patent_doc_number] => 06391657
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Removal of viruses from protein solutions by ultrafiltration'
[patent_app_type] => B1
[patent_app_number] => 08/598264
[patent_app_country] => US
[patent_app_date] => 1996-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1855
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391657.pdf
[firstpage_image] =>[orig_patent_app_number] => 08598264
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/598264 | Removal of viruses from protein solutions by ultrafiltration | Feb 6, 1996 | Issued |
Array
(
[id] => 3616890
[patent_doc_number] => 05688501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system'
[patent_app_type] => 1
[patent_app_number] => 8/593269
[patent_app_country] => US
[patent_app_date] => 1996-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7787
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688501.pdf
[firstpage_image] =>[orig_patent_app_number] => 593269
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/593269 | Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system | Jan 28, 1996 | Issued |
| 08/586176 | IN VITRO PEPTIDE AND ANTIBODY DISPLAY LIBRARIES | Jan 16, 1996 | Abandoned |
Array
(
[id] => 3884091
[patent_doc_number] => 05776784
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Apparatus and method for reagent separation in a chemical analyzer'
[patent_app_type] => 1
[patent_app_number] => 8/585333
[patent_app_country] => US
[patent_app_date] => 1996-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5309
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776784.pdf
[firstpage_image] =>[orig_patent_app_number] => 585333
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/585333 | Apparatus and method for reagent separation in a chemical analyzer | Jan 10, 1996 | Issued |
Array
(
[id] => 4244345
[patent_doc_number] => 06136555
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Purification method and apparatus'
[patent_app_type] => 1
[patent_app_number] => 8/571864
[patent_app_country] => US
[patent_app_date] => 1996-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 6755
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136555.pdf
[firstpage_image] =>[orig_patent_app_number] => 571864
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/571864 | Purification method and apparatus | Jan 3, 1996 | Issued |
| 08/560093 | METHOD FOR DETECTING AND DETERMINING MEDIATORS | Nov 16, 1995 | Abandoned |
Array
(
[id] => 4005879
[patent_doc_number] => 05888813
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Monoclonal antibodies against human pancreatic islet cells'
[patent_app_type] => 1
[patent_app_number] => 8/554796
[patent_app_country] => US
[patent_app_date] => 1995-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5788
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/888/05888813.pdf
[firstpage_image] =>[orig_patent_app_number] => 554796
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/554796 | Monoclonal antibodies against human pancreatic islet cells | Nov 6, 1995 | Issued |
Array
(
[id] => 3733678
[patent_doc_number] => 05698408
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Pterin derivatives the preparation thereof and the use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/525553
[patent_app_country] => US
[patent_app_date] => 1995-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3861
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698408.pdf
[firstpage_image] =>[orig_patent_app_number] => 525553
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/525553 | Pterin derivatives the preparation thereof and the use thereof | Nov 1, 1995 | Issued |
| 08/543227 | PROCESS FOR IMMUNOCHROMATOGRAPHY WITH COLLOIDAL PARTICLES | Oct 12, 1995 | Abandoned |
Array
(
[id] => 4352359
[patent_doc_number] => 06214970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Hepatitis E virus antigens and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/542634
[patent_app_country] => US
[patent_app_date] => 1995-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 27365
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214970.pdf
[firstpage_image] =>[orig_patent_app_number] => 542634
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/542634 | Hepatitis E virus antigens and uses therefor | Oct 12, 1995 | Issued |
Array
(
[id] => 3721917
[patent_doc_number] => 05672471
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Assay for detection and/or quantifying a mammalian IgA antibody response to Epstein-Barr virus membrane antigen using EBV-MA gp 350/220 lacking the transmembrane anchor domain'
[patent_app_type] => 1
[patent_app_number] => 8/542234
[patent_app_country] => US
[patent_app_date] => 1995-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4417
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672471.pdf
[firstpage_image] =>[orig_patent_app_number] => 542234
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/542234 | Assay for detection and/or quantifying a mammalian IgA antibody response to Epstein-Barr virus membrane antigen using EBV-MA gp 350/220 lacking the transmembrane anchor domain | Oct 11, 1995 | Issued |
Array
(
[id] => 3784134
[patent_doc_number] => 05736321
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Peptides effective for diagnosis and detection of hepatitis C infection'
[patent_app_type] => 1
[patent_app_number] => 8/530550
[patent_app_country] => US
[patent_app_date] => 1995-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19774
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736321.pdf
[firstpage_image] =>[orig_patent_app_number] => 530550
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/530550 | Peptides effective for diagnosis and detection of hepatitis C infection | Sep 18, 1995 | Issued |
Array
(
[id] => 3927794
[patent_doc_number] => 05928647
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Inducing cytotoxic T lymphocyte responses'
[patent_app_type] => 1
[patent_app_number] => 8/481327
[patent_app_country] => US
[patent_app_date] => 1995-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 25
[patent_no_of_words] => 12647
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928647.pdf
[firstpage_image] =>[orig_patent_app_number] => 481327
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481327 | Inducing cytotoxic T lymphocyte responses | Sep 14, 1995 | Issued |
Array
(
[id] => 4171080
[patent_doc_number] => 06083708
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Polypeptide: dendrimer complexes'
[patent_app_type] => 1
[patent_app_number] => 8/514075
[patent_app_country] => US
[patent_app_date] => 1995-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 5
[patent_no_of_words] => 14033
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083708.pdf
[firstpage_image] =>[orig_patent_app_number] => 514075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/514075 | Polypeptide: dendrimer complexes | Aug 10, 1995 | Issued |